Evidence map›Paper›PMID 32915409›Full record

ArticleAdvances in therapy2020

Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis.

Pietro Lampertico, Stefan Mauss, Marcello Persico, Stephen T Barclay, Steven Marx, Kristina Lohmann, Mark Bondin, ZhenZhen Zhang, Fiona Marra, Pamela S Belperio and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Pietro LamperticoDivision of Gastroenterology and Hepatolgy, CRC "A.M. and A.Migliavacca" Center for Liver Disease, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. pietro.lampertico@unimi.it.ORCID http://orcid.org/0000-0002-1026-7476
Stefan MaussCenter for HIV and Hepatogastroenterology, Düsseldorf, Germany.
Marcello PersicoInternal Medicine and Hepatology Unit, University of Salerno, Salerno, Italy.
Stephen T BarclayDepartment of Life Sciences, Glasgow Caledonian University, Glasgow, UK.
Steven MarxAbbVie Inc., North Chicago, IL, USA.
Kristina LohmannAbbVie Deutschland GmBH Co. KG, Wiesbaden, Germany.
Mark BondinAbbVie Inc., North Chicago, IL, USA.
ZhenZhen ZhangAbbVie Inc., North Chicago, IL, USA.
Fiona MarraUniversity of Liverpool Hepatology Drug Interactions Group, Liverpool, UK.
Pamela S BelperioDepartment of Veterans Affairs, VA Palo Alto Healthcare System, Palo Alto, CA, USA.
Heiner WedemeyerDepartment of Gastroenterology and Hepatology, Essen University Hospital, Essen, Germany.
Steven FlammNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original article, there is an error in Fig. 1.

Identifiers

PMID32915409
PMCPMC7547987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.